Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis (2005)
- Autores:
- Autores USP: NOGUEIRA, ANTONIO ALBERTO - FMRP ; FERRIANI, RUI ALBERTO - FMRP
- Unidade: FMRP
- Assunto: ENDOMETRIOSE
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: European journal of obstetrics & gynecology and reproductive biology
- ISSN: 0301-2115
- Volume/Número/Paginação/Ano: v. 123, p. S40, res. 057, 2005
- Nome do evento: World congress on endometriosis
-
ABNT
ROSA E SILVA, Ana Carolina Japur de Sá et al. Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis. European journal of obstetrics & gynecology and reproductive biology. Co Clare: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 abr. 2024. , 2005 -
APA
Rosa e Silva, A. C. J. de S., Rosa e Silva, J. C., Nogueira, A. A., Reis, F. J. C. dos, Petta, C. A., Abrão, M. S., & Ferriani, R. A. (2005). Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis. European journal of obstetrics & gynecology and reproductive biology. Co Clare: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Rosa e Silva ACJ de S, Rosa e Silva JC, Nogueira AA, Reis FJC dos, Petta CA, Abrão MS, Ferriani RA. Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis. European journal of obstetrics & gynecology and reproductive biology. 2005 ; 123 S40.[citado 2024 abr. 16 ] -
Vancouver
Rosa e Silva ACJ de S, Rosa e Silva JC, Nogueira AA, Reis FJC dos, Petta CA, Abrão MS, Ferriani RA. Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis. European journal of obstetrics & gynecology and reproductive biology. 2005 ; 123 S40.[citado 2024 abr. 16 ] - The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis
- Effects of the levonorgestrel releasing intra-uterine system on uterine and ovarian volumes, endometrial thickness and dopplervelocimetry of uterine arteries, in women with pelvic endometriosis
- Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction
- Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Use of levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Comparative cell proliferation study in superficial and deep endometriotic lesions
- Levonorgestrel intra-uterine device effects on endometriosis
- Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue
- Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist
- Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
